News

According to Power Medical Interventions (PMI), the iDrive Intelligent Power Unit (IPU), a first-of-its-kind breakthrough in operating room instrumentation, is designed to support a variety of minimally invasive

According to Insulet, the OmniPod insulin management system is the first and only continuous insulin delivery system of its kind in the market. The OmniPod system offers people

The Phase I healthy volunteer study of IMX942 will provide human safety and pharmacodynamic data, said Inimex. IMX942 is the first of a new class of drugs known

Existing investors Aescap Venture, Entrepreneurs Fund and Z-Cube also participated in the series B financing. Regina Hodits of Atlas Venture and Deborah Harland of SR One will join

According to Etex, Beta-bsm and Gamma-bsm set hard to provide an optimal osteoconductive scaffold that mimics the nanocrystalline structure of human bone. Smaller sizes were developed in direct

Sinobiopharma has acquired rights to the following patents – Synthesis of amantadine hydrochloride, method for preparation of 17-acylsinomenine derivatives, preparation of 17-sulfonylsinomenine, preparation of N-substituted sinomenine, method for

Diagnostics to rapidly screen individual patients for influenza virus in hospitals, clinics and doctors’ offices, personal protection devices such as facemasks to help stop the spread of disease,

The company has reported net revenues of $10.9 billion for the first quarter of 2009, a decrease of 8%, compared to $11.85 billion for the first quarter of

Net revenue for the fourth quarter of 2008 was $7.06 million, a decrease of 14.5% from $8.32 million for the fourth quarter of 2007. The decrease in net